A single unit of donated blood carries more potential than most people realise. Separated with the right equipment and expertise, it becomes red cells for a patient in surgery, plasma for someone in liver failure, platelets for a cancer patient, and cryoprecipitate for a bleeding disorder — each component going to exactly the patient who needs it.
Jeevan Jyoti Blood Centre & Components was Central India’s first facility to offer this level of component separation, and today we prepare and issue twenty licensed blood components and services under our FDA licence (ND/BB/11). The table below sets out what each component is, what it treats, and how it’s stored — information every referring doctor, hospital and curious donor should be able to find easily.
| Blood Component | Description | Primary Uses | Storage Temperature | Shelf Life |
|---|---|---|---|---|
| Whole Human Blood | Blood containing red cells, plasma, platelets and clotting factors | Massive blood loss, exchange transfusion (limited use) | 2-6°C | 35 days (CPDA-1) or up to 42 days (additive solution) |
| Concentrate of Human Red Cells (Packed Red Cells) | Red blood cells with most plasma removed | Treatment of anaemia and acute blood loss | 2-6°C | 35-42 days (depending on preservative) |
| Fresh Frozen Plasma (FFP) | Plasma frozen soon after collection to preserve clotting factors | Coagulation factor deficiencies, liver disease, massive transfusion | ≤ -18°C | Up to 1 year at ≤ -18°C; longer at colder temperatures per policy |
| Platelet Concentrate | Platelets prepared from whole blood | Prevention and treatment of bleeding due to thrombocytopenia | 20-24°C with continuous agitation | 5-7 days |
| Platelet Rich Plasma (PRP) | Plasma containing a high concentration of platelets | Preparation of platelet concentrates; select therapeutic uses | 20-24°C | Processed promptly; if transfused, 5-7 days |
| Red Blood Cells (Leukoreduced / Leucodepleted) | Packed red cells with most white cells removed | Reduces febrile reactions, CMV transmission risk, HLA alloimmunisation | 2-6°C | 35-42 days |
| Cryoprecipitate (AHF) | Concentrated fibrinogen, Factor VIII, Factor XIII, vWF and fibronectin | Hypofibrinogenemia, massive haemorrhage, Factor XIII deficiency | ≤ -18°C | Up to 1 year |
| Platelets - Leucodepleted | Platelet concentrate with reduced leukocyte content | Reduced risk of febrile reactions or alloimmunisation | 20-24°C with agitation | 5-7 days |
| Liquid Plasma / Single Donor Plasma | Plasma separated but not frozen immediately | Plasma protein replacement (limited indications), fractionation | 1-6°C | Up to 5 days (varies by regulation) |
| Cryoprecipitate Reduced Plasma (Cryo Poor Plasma) | Plasma remaining after cryoprecipitate removal | Therapeutic plasma exchange (e.g. TTP), coagulation support | ≤ -18°C | Up to 1 year |
| Apheresis Leukocytes / Leukocytopheresis | Leukocyte concentrate collected by apheresis | Severe neutropenia with life-threatening infection (rare indication) | 20-24°C | Transfuse as soon as possible, within 24 hours |
| Apheresis Platelet / Single Donor Platelets (SDP) | Platelets collected from one donor by apheresis | Platelet transfusion with reduced donor exposure | 20-24°C with agitation | 5-7 days |
| Apheresis Hematopoietic Stem Cells (Peripheral Blood Stem Cells) | Peripheral blood stem cells collected by apheresis | Hematopoietic stem cell transplantation | 2-8°C short-term; ≤ -150°C cryopreserved | Fresh: up to 72 hours; cryopreserved: years under validated storage |
| Granulocyte Concentrate | Concentrated granulocytes collected by apheresis | Severe neutropenia with refractory infections | 20-24°C | Transfuse within 24 hours |
| Saline Washed Red Blood Cells | Red cells washed to remove plasma proteins | Severe allergic transfusion reactions, IgA deficiency | 1-6°C | Within 24 hours of washing (closed/open system dependent) |
| Packed Red Cell Aliquots | Small-volume aliquots of packed red cells | Neonatal and paediatric transfusions | 2-6°C | Up to 24 hours after aliquoting in an open system (method-dependent) |
| Leukoreduced Single Donor Platelets by Apheresis | Apheresis platelets with leukocyte reduction | Platelet support with reduced alloimmunisation and febrile reactions | 20-24°C with agitation | 5-7 days |
| Pooled Platelets | Platelets pooled from multiple whole-blood donations | Treatment of thrombocytopenia and bleeding | 20-24°C with agitation | 5-7 days (per local regulation after pooling) |
| Pooled Cryoprecipitate | Multiple cryoprecipitate units pooled before transfusion | Rapid fibrinogen replacement in bleeding patients | ≤ -18°C frozen; 20-24°C after thawing | Frozen: up to 1 year; after thawing, use within 4-6 hours |
| PBSC - Stem Cell Harvest | Peripheral blood stem cell collection for transplantation | Autologous or allogeneic stem cell transplantation | 2-8°C fresh; ≤ -150°C cryopreserved | Fresh: within 72 hours; cryopreserved: years under validated storage |